Rapport Therapeutics RAPP
$23.16 −$0.43 (-1.82%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $23.16 0.00%
Open$23.23
Prev close$23.59
Day range$23.00 – $23.83
Volume437.7K
Market cap$1.37B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts14
Average target$68.00+193.6% vs. price
- Buy 100%
Low $47.00Now $23.16Avg $68.00High $91.00
Recent rating changes
The last 20 actions on file set price targets from $47.00 to $91.00, averaging $65.17.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | JonesTrading | BUY | $82.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $47.00 |
| 5 Nov 2026 | UBS | BUY | $64.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $63.00 |
| 4 Nov 2026 | Wells Fargo | BUY | $47.00 |
| 4 Nov 2026 | Guggenheim | BUY | $66.00 |
| 21 Oct 2026 | Wells Fargo | BUY | $50.00 |
| 21 Oct 2026 | JonesTrading | BUY | $82.00 |
| 21 Oct 2026 | Goldman Sachs | BUY | $68.00 |
| 20 Oct 2026 | Wells Fargo | BUY | $50.00 |
| 20 Oct 2026 | Raymond James | BUY | $86.00 |
| 20 Oct 2026 | Citizens JMP | BUY | $91.00 |
| 20 Oct 2026 | Guggenheim | BUY | $70.00 |
| 20 Oct 2026 | H.C. Wainwright | BUY | $66.00 |
| 16 Oct 2026 | Wells Fargo | BUY | $51.00 |
| 15 Oct 2026 | Wolfe Research | BUY | $50.00 |
| 5 Oct 2026 | Guggenheim | BUY | $65.00 |
| 1 Oct 2026 | BTIG | BUY | $75.00 |
| 23 Sep 2026 | Raymond James | BUY | – |
| 23 Sep 2026 | Truist Financial | BUY | – |
No comments yet — be the first to weigh in on RAPP.
Sign in to join the discussion.